COMMUNIQUÉS West-GlobeNewswire

MediPharm Labs Corp. Receives Sales Licence from Health Canada
12/11/2018
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (“ MediPharm Labs ” or the “ Company ”) (TSXV: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has received its sales [...]
Ossur Hf : Transactions in relation to share buyback program
12/11/2018
Announcement no. 66/2018 12 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Abeona Therapeutics annonce ses résultats financiers et les faits marquants du troisième trimestre 2018
12/11/2018
Conférence téléphonique est organisée pour les investisseurs le lundi 12 novembre à 10h00 ET (16h00 CET) NEW YORK et CLEVELAND, 12 nov. 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), une société [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
12/11/2018
FIT Biotech Oy Company release November 12, 2018 at 5:45 PM EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech [...]
Jefferson and Teladoc Introduce First Telehealth Fellowship
12/11/2018
Academic influencer and market leader in virtual care partner to advance telehealth PURCHASE, NY, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today unveiled a [...]
Physeon Announces Enrollment of First Patient in US “VIVA” Trial for Veinplicity
12/11/2018
Important Milestone for Veinplicity Study SCHAFFHAUSEN, Switzerland, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, [...]
Nemaura Medical to Present at the Stifel 2018 Healthcare Conference
12/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]
Mersana Therapeutics Presents Pre-clinical Data at AACR-NCI-EORTC on Two Additional, Proprietary Antibody Drug Conjugate Platforms and a Pre-clinical Update for XMT-1522 in Non-small Cell Lung Cancer
12/11/2018
CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Biodesix Test Predicts Response to Atezolizumab in Lung Cancer
12/11/2018
Researchers Present New Data from Blood-Based Proteomic Test in Biomarkers and Immune Monitoring at SITC 2018 BOULDER, Colo. and WASHINGTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Researchers with Biodesix ® and Genentech, a [...]
Corvus Pharmaceuticals to Present at the 27th Annual Credit Suisse Healthcare Conference
12/11/2018
BURLINGAME, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntington’s Disease at the Huntington Study Group’s 2018 Annual Meeting
12/11/2018
Presentation and Poster Include Previously Announced Results of Cohort A of SIGNAL Trial ROCHESTER, N.Y., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged [...]
CLS Holdings USA Announces City Trees Booth at MJBizCon
12/11/2018
Meet the City Trees Team at Booth #3913 City Trees Products Available in 35 Nevada Dispensaries City Trees Considers Expansion Beyond Nevada LAS VEGAS, Nov. 12, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: [...]
Gabriella's Kitchen Is Redefining The Cannabis Health and Wellness Industry -- CFN Media
12/11/2018
SEATTLE, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Cellectar Announces FDA Grants Exemption to Import Alert for CLR 131 Hematology Studies
12/11/2018
Clinical Trials to Advance Across Multiple Hematology Programs FLORHAM PARK, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]
Teligent, Inc. to Hold Conference Call for Third Quarter 2018 Results
12/11/2018
BUENA, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Tuesday [...]
Anchiano Therapeutics Appoints Dr. Stephen Hoffman and Robert Connelly to Its Board of Directors
12/11/2018
Dr. Hoffman joins the Board as Chairman Mr. Connelly is appointed as a Director CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. ( TASE: ANCN ), a clinical-stage biopharmaceutical company [...]
GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions
12/11/2018
AF detection by implanted Medtronic devices Similar trends for benefit in favor of Gencaro compared to active comparator for AF risk reduction observed by continuous monitoring with implanted devices compared to [...]
VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of Depression
12/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Notice of Annual General Meeting
12/11/2018
Please see enclosed pdf. Attachment Notice

Pages